The invention provides a gastric
cancer risk detection device based on a
big data analysis technology, and relates to the field of
medical treatment. The gastric
cancer disease risk detection device based on the
big data analysis technology comprises a
data acquisition module which comprises multi-
modal data acquisition including
genome data,
metabolome data, iconography data,
environmental data and electronic health records, and is used for acquiring
genome data of a user, especially
gene mutation related to gastric
cancer, and detecting the risk of the gastric cancer
disease according to the
genome data, the
metabolome data, the iconography data, the
environmental data and the electronic health records. The method comprises the following steps of: acquiring a plurality of health records of a patient, performing
gene data acquisition by using
gene sequencing equipment, transmitting
metabolome data into a
system, associating the metabolome data with other
health data of the user, uploading the metabolome data to the
system through a network, and acquiring
medical record data of the patient from medical records of a hospital, including past medical histories, family medical histories, medication records and the like, by using the electronic health records. By arranging the
data acquisition module, the accuracy of gastric
cancer risk assessment is improved, and by arranging the data storage module, safe sharing and
traceability of data are realized, and the authenticity and reliability of the data are ensured.